Table 2.
Lipid-based nanomedicines | Inorganic/metal-based nanomedicines | Polymeric-based nanomedicines | |
---|---|---|---|
Methods of production |
High-pressure homogenization (hot and cold) Membrane contractor method Microemulsion Solvent diffusion Solvent evaporation Ultrasound High-shear homogenization |
Chemical methods (metal complex reduction) Physical methods (laser pulses, supercritical fluid, chemical vapor deposition, microwave radiation) |
Extrusion Ionic gelation Nanoprecipitation Salting out Supercritical fluid Bioconjugation Tangential flow filtration |
Critical factors |
Hydrophilicity of drug Polydispersity index Particle size Lab-scale vs. Industrial-scale Temperature Organic solvent Structural organization |
Hydrophilicity of drug Polydispersity index Particle size Type of solvent Organic solvent Surface-to-volume ratio |
Polydispersity index Particle size Non-volatile impurities as bioconjugation subproducts Structural organization Bioresponsiveness |